[Recent topics on paraneoplastic neurological syndromes: anti-VGKC antibodies].
Watanabe
Osamu
O
Arimura
Kimiyoshi
K
D000818:Animals; D000912:Antibodies, Neoplasm; D001323:Autoantibodies; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D007167:Immunotherapy; D020386:Isaacs Syndrome / Q000276:immunology; D020363:Limbic Encephalitis / Q000150:complications / Q000628:therapy; D009378:Neoplasms, Multiple Primary; D020361:Paraneoplastic Syndromes, Nervous System / Q000276:immunology* / Q000628:therapy; D010951:Plasma Exchange; D024642:Potassium Channels, Voltage-Gated / Q000276:immunology*; D013945:Thymoma / Q000150:complications / Q000628:therapy; D013953:Thymus Neoplasms / Q000150:complications / Q000628:therapy
D000912:Antibodies, Neoplasm; D001323:Autoantibodies; D005938:Glucocorticoids; D024642:Potassium Channels, Voltage-Gated